Clinical Trial Update: Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating omega-3 fatty acid supplementation on inflammatory response in patients with polytrauma has terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polytrauma

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Cincinnati | Conditions: Multiple Trauma | Phase 1, Phase 2 | Status: TERMINATED